FONTEYNE PAUL R.

CIK 00017275506 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001727550

Recent Transactions

50 trades

Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2026-06-04+24,372→ 24,372 total
Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−30,666→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,062→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−5,744→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−7,961→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,544→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−3,877→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−14,684→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−37,500→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−11,199→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−8,554→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−7,441→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−27,600→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−5,748→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-01+7,961→ 30,666 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2026-01-01+14,684→ 14,684 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2025-06-05+25,000→ 25,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-01+6,267→ 22,705 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-01-01+11,199→ 11,199 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-06-06+25,000→ 25,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-01+3,341→ 16,438 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-01$59.86/sh+5,748→ 5,748 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-06-08+16,985→ 16,985 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-01+3,867→ 13,097 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-01+7,441→ 7,441 total
Disposition to Issuer
COVETRUS, INC.
Common Stock
2022-10-13−13,275→ 0 total
Disposition to Issuer
COVETRUS, INC.
Restricted Stock Units
2022-10-13−14,638→ 0 total
Exercise/Conversion
COVETRUS, INC.
Common Stock
2022-07-01+8,275→ 13,275 total
Exercise/Conversion
COVETRUS, INC.
Restricted Stock Units
2022-07-01−8,275→ 0 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2022-06-09+19,000→ 19,000 total
Award
COVETRUS, INC.
Restricted Stock Units
2022-05-11+14,638→ 14,638 total
Award
GELESIS HOLDINGS, INC.
Common Stock
2022-05-06+53,832→ 53,832 total
Purchase
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-01-06$19.00/sh+3,947→ 3,947 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2022-01-06+8,400→ 8,400 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-01+8,554→ 8,554 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-01+4,230→ 9,230 total
Purchase
COVETRUS, INC.
Common Stock
2021-08-10$23.24/sh+5,000→ 5,000 total
Award
COVETRUS, INC.
Restricted Stock Units
2021-07-01+8,275→ 8,275 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-01+27,600→ 27,600 total
Disposition to Issuer
AMAG PHARMACEUTICALS, INC.
Common Stock
2020-11-16−14,676→ 0 total
Disposition to Issuer
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-11-16−6,000→ 0 total
Disposition to Issuer
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-11-16−21,289→ 0 total
Disposition to Issuer
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-11-16−9,452→ 0 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2020-06-03+14,414→ 14,414 total
Award
AMAG PHARMACEUTICALS, INC.
Common Stock
2020-06-02+10,269→ 14,676 total
Award
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-06-02+21,289→ 21,289 total
Purchase
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-05-08$31.81/sh+5,000→ 5,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2020-04-02+37,500→ 37,500 total
Award
AMAG PHARMACEUTICALS, INC.
Common Stock
2019-10-08+4,407→ 4,407 total
Award
AMAG PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2019-10-08+6,000→ 6,000 total

Companies

Recent Filings

Address

C/O AMYLYX PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 6W

CAMBRIDGE, MA, 02142

View on SEC.gov